Experimental COVID-19 drug Remdesivir approved for use

Posted at 9:05 AM, May 14, 2020
and last updated 2020-05-14 09:10:36-04

The FDA has issued an emergency use authorization for the drug Remdesivir, giving doctors permission to give it to coronavirus patients.

Studies up to this point suggest that Remdesivir can shorten the duration of a COVID-19 infection from 15 days to 11.

Health experts admit that the drug still needs more testing, but say getting it into our hospitals is a step in the right direction.

The Ohio Department of Health now has about 20 cases of the drug, enough to treat 100 people.

Vials will be sent to hospitals around the state that have the most cases of mechanically ventilated patients battling COVID-19.

Tony Kahle, a COVID-19 patient in San Diego, said Remdesivir saved his life.

“I was in a medically induced coma so I don't remember a whole lot about the whole process -- thankful that I was able to receive it early and got such great care. There's sadness that people may die because they can't get this drug,” Kahle said.

Kentucky health commissioner Dr. Steven Stack said the state has received ten cases of Remdesivir, some of which have gone to a medical center in Bowling Green.

“We will continue to provide additional support to them and continue our dialogue and discussions,” Stack said during Wednesday’s briefing.

Indiana officials say they’ve also received two shipments of the drug and will begin receiving shipments weekly.